No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Tilcotil Generic Tenoxicam

No Prescription » Prescription Drugs 16 » Tilcotil Generic Tenoxicam

Therapeutic Indications:Tilcotil is indicated for the symptomatic treatment of the following painful inflammatory and degenerative disorders of the musculoskeletal system:1. rheumatoid arthritis; 2. osteoarthritis; 3. arthrosis; 4. ankylosing spondylitis; 5. extra-articular disorders e.g. tendinitis bursitis periarthritis of shoulders (shoulder-hand syndrome) or hips strains and sprains; 6. post-operative pain.Tilcotil tablets are also indicated for:1. acute gout 2. primary dysmenorrhea.Dosage and Method of AdministrationStandard dosageAfter assessing the risk/benefit ratio in each individual patient the lowest effective dose for the shortest possible duration should be used.For all indications except primary dysmenorrhoea post-operative pain and acute gout a daily dosage of 20 mg should be given at the same time of day.The recommended dose for primary dysmenorrhoea is 20 to 40 mg once daily. For post-operative pain the recommended dose is 40 mg once daily up to five days and for acute attacks of gout the recommended dose is 40 mg once daily for two days followed by 20 mg once daily for a further five days. In treatment of chronic disorders the therapeutic effect of tenoxicam is evident early in treatment and there is a progressive increase in response over time. In chronic disorders daily doses higher than 20 mg are not recommended since this would increase the frequency and intensity of unwanted reactions without significantly increasing efficacy.For patients needing long-term treatment a reduction to a daily oral dose of 10 mg may be tried for maintenance.The tablets should be taken with a glass of water. It is preferable to take this medicine during or immediately after a meal.Special dosage instructionsIn principle the above dosage recommendations also apply to elderly patients and to patients suffering from kidney or liver disease. Dosage should be minimised in the elderly and in patients with renal impairment.Because of lack of clinical experience no dosage recommendations have so far been established for children and adolescents.

Buy Tilcotil Generic Tenoxicam and other Prescription Drugs 16 products online at Medstore.

5625
Buy Online at Medstore - Click Here!

About Tilcotil Generic Tenoxicam:

Product Type: Prescription Drugs 16

Tilcotil ( Generic Tenoxicam )

Tilcotil (Generic Tenoxicam)

Generic Tenoxicam

20mg 100 Tablets Generic Tenoxicam Tilcotil

View more Prescription Drugs 16

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.